← Back to Search

Platelet-rich Plasma

PRP treatment for Lower Back Pain

N/A
Waitlist Available
Led By Christopher Centeno, MD
Research Sponsored by Regenexx, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months, 6 months, 12 months
Awards & highlights

Study Summary

This study is evaluating whether injections of different substances into the back may help treat lower back pain.

Eligible Conditions
  • Lower Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-treatment MRI
Secondary outcome measures
Functional Rating Index
Numeric Pain Scale
Oswestry Low Back Disability Index
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: PRP treatmentExperimental Treatment1 Intervention
5x concentration Platelet Rich Plasma (PRP) injected into the multifidus on each side and at each level 1 time per week for 6 weeks (series of 6 injections)
Group II: PRP and PL Combo treatmentExperimental Treatment1 Intervention
5x concentration PRP injected into the multifidus, along with a facet joint injection with 14x PRP into each joint and capsule, and transforaminal epidural injection with of 3x concentrated platelet lysate (PL) and 0.5% ropivacaine on each side and at each level 1 time every 2 weeks for 6 weeks total (series of 3 injections)
Group III: PPP treatmentExperimental Treatment1 Intervention
Platelet Poor Plasma (PPP) into the multifidus on each side and at each level 1 time per week for 6 weeks (series of 6 injections)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PRP treatment
2022
N/A
~20

Find a Location

Who is running the clinical trial?

Regenexx, LLCLead Sponsor
14 Previous Clinical Trials
50,837 Total Patients Enrolled
Christopher Centeno, MDPrincipal InvestigatorCenteno-Schultz Clinic
12 Previous Clinical Trials
50,389 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Colorado
How old are they?
18 - 65
What site did they apply to?
Centeno-Schultz Clinic
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain
2019. "A Trial Comparing Three Orthobiologic Therapies on Atrophied Multifidus Muscles in Patients With Low Back Pain". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03618979.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top